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ABSTRACT
Site-directed RNA editing (SDRE) is a strategy to
precisely alter genetic information within mRNAs.
By linking the catalytic domain of the RNA editing
enzyme ADAR to an antisense guide RNA, specific
adenosines can be converted to inosines, biological
mimics for guanosine. Previously, we showed that
a genetically encoded iteration of SDRE could tar-
get adenosines expressed in human cells, but not
efficiently. Here we developed a reporter assay to
quantify editing, and used it to improve our strat-
egy. By enhancing the linkage between ADAR’s cat-
alytic domain and the guide RNA, and by introduc-
ing a mutation in the catalytic domain, the efficiency
of converting a UAG premature termination codon
(PTC) to tryptophan (UGG) was improved from ∼11
% to ∼70 %. Other PTCs were edited, but less effi-
ciently. Numerous off-target edits were identified in
the targeted mRNA, but not in randomly selected en-
dogenous messages. Off-target edits could be elim-
inated by reducing the amount of guide RNA with a
reduction in on-target editing. The catalytic rate of
SDRE was compared with those for human ADARs
on various substrates and found to be within an or-
der of magnitude of most. These data underscore the
promise of site-directed RNA editing as a therapeutic
or experimental tool.
INTRODUCTION
Many of the most powerful tools in modern biology and
medicine enable the manipulation of genetic information.
In biology, they allow the researcher to characterize the
function of gene products and the roles that they play in
larger networks. In medicine, they regulate gene expression
and hold tremendous promise for the correction of genetic
mutations and the fine-tuning of protein function. To date,
most approaches focus on knocking out genes, or manipu-
lating their expression levels using processes like RNA in-
terference (1,2). More recently, strategies for genome edit-
ing have unlocked more subtle manipulations, allowing re-
searchers to alter protein function through codon-level en-
gineering (3). A common theme among all strategies is that
they are based on naturally occurring enzymatic systems.
Although most focus on DNA, in theory, genetic informa-
tion can be manipulated at any point before being realized
as a protein.
RNA editing by adenosine deamination is a natural pro-
cess of site-directed mutagenesis used by all true metazoans.
It is catalyzed by the ADAR (Adenosine Deaminase that
Acts on RNA) family of enzymes, which convert adenosine
(A) to inosine (I) through a simple hydrolytic deamination
(4–8). During translation and other biological processes, I
is interpreted as guanosine (G; 9); thus the introduction of
I within codons can recode them. Although A’s make up
about a quarter of all bases in RNAs, ADARs have the re-
markable capacity to select specific ones for deamination.
ADARs are modular, being composed of double stranded
RNA binding motifs (dsRBMs) followed by a catalytic do-
main, often referred to as the deaminase domain (DD; 6,8).
To edit a specific A, the dsRBMs bind to imperfect double-
stranded structures and position the DD next to the target
A (10). Obviously, RNA editing could be a useful tool if
it could be directed towards a chosen A. The endogenous
targeting mechanism, however, presents a barrier because
it requires structures in cis, and these would be difficult to
create.
Two similar strategies have been developed to target
ADARs (11–16). For both, the dsRBMs have been removed
and replaced with an antisense RNA guide. Because the
RNA guide can be designed to bind to any primary RNA se-
quence, targeting is simple, depending only on Watson and
Crick base-pairing. The RNA guide also plays the added
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role of providing the double-stranded structure required by
the DD (10). The two strategies differ by the way the DD
is linked to the RNA guide. Our group has used the N
peptide-boxB hairpin RNA interaction, a small RNA bind-
ing protein and its target (11,17–19). The N peptide is
fused to the N-terminus of the DD from human ADAR2
(N-DD), and the boxB hairpin is fused to the RNA guide.
Although the interaction is not covalent, it is of nanomolar
affinity and the components are small, making it less likely
that they will interfere with the activity of the DD (11). This
strategy allows both the guide and the editing enzyme to
be fully genetically encoded, an important consideration for
future delivery schemes. It also permits the relative propor-
tion of the guide RNA and DD to be adjusted. Another
group has used a SNAP-tag to join the DD to the RNA
guide (12–16). This approach has the advantage of using a
covalent interaction, and it also allows the addition of mod-
ified nucleotides to the guide RNA to provide added stabil-
ity and specificity. Although the SNAP-tag containing DD
is genetically encodable, the guide RNA must be delivered in
its final form because it needs to be synthesized with a ben-
zylguanine derivative, the substrate for the SNAP-tag. Both
strategies have shown good success and hold much promise
in developing the future potential of SDRE.
Although SDRE has been effectively employed to edit
specific A’s, there are hurdles to overcome. Thus far it has
been effective in vitro, in Xenopus oocytes, in human cells,
and, for the first time, in a simple animal model (annelid;
11–16); However, the extent of editing has not been rigor-
ously quantified in cells. Using the N-boxB system, editing
was highly efficient when purified components were used in
vitro. Using a semi-genetically encoded system in Xenopus
oocytes, editing was moderately efficient. A fully genetically
encoded version in human cells edited at low efficiency. An-
other issue is that the DD of ADAR prefers A’s surrounded
by specific neighbors (20,21), making some A’s easier to tar-
get than others. Finally, the extent of off-target editing has
not been rigorously evaluated. In this work, we systemati-
cally improved the N-boxB system so that it can efficiently
edit A’s in a variety of neighboring contexts within human
cells. In addition, we quantified off-target editing, deter-
mined how to reduce it, and compared the reaction kinetics
of N-DD with WT ADAR.
MATERIALS AND METHODS
Molecular biology
Because our experiments required three elements, we de-
scribe the production of the RNA guides, the various N-
DDs, and the target mRNAs separately. RNA guides were
used for in vitro and in cellula experiments, and in each
case they were made differently. For in vitro RNA guides,
double-stranded oligo templates were synthesized with a
T7 promoter and RNA was transcribed directly from them
using the mScript™ Standard mRNA Production System
(CellScript, Madison, WI, USA). For in cellula experiments,
double stranded DNA oligonucleotides encoding the guide
were cloned into the BLOCK-iT™ U6 RNAi Entry Vector
(Invitrogen, Carlsbad, CA, USA).
The original N-DD construct has been described pre-
viously (11). Sequence encoding additional Ns, and a
short linker to connect them, was added to the N-
terminus by synthesizing corresponding gene blocks and
cloning them into the original vector by the Gibson As-
sembly Method (Gibson Assembly® Master Mix Kit,
New England Biolabs, Ipswich, MA). A single N-
linker unit was MNARTRRRERRAEKQAQWKAAN–
GGGGSGGGGSGGGGS. The same approach was used
to introduce the R7K, R8K, and R11K mutants into
both N-DD and 4N-DD (see Supporting Table S1).
The E488Q mutation was added to the DD using the
Quikchange Lightning Site-directed Mutagenesis kit (Ag-
ilent Technologies, Santa Clara, CA). The no-N construct
was made from N-DD using inverse PCR (see Supporting
Table S1).
There were two target mRNAs for this study: CFTR and
mCherry-eGFP. CFTR, which was kindly provided by Dr.
David Gadsby from the Rockefeller University, New York,
has been described previously (11). CFTR RNA was used as
a generic in vitro target, and was used only for the purpose
of optimizing RNA guides. CFTR RNA was transcribed
using the T7 RNA polymerase and the same RNA produc-
tion kit above. The mCherry-eGFP and the mCherry-eGFP
W58X constructs were synthesized by Genewiz, Inc. (South
Plainfield, NJ) and subcloned via the XhoI and BamHI
restriction sites into pcDNA 3.1(−) (Invitrogen, Carlsbad,
CA, USA). This construct was used for RNA synthesis us-
ing the T7 RNA polymerase and the same RNA produc-
tion kit and was also used for transfection into cells. For
experiments involving PTCs in different neighboring con-
texts, the Quikchange Lightning Site-Directed Mutagenesis
Kit was used to introduce substitutions at W58 and Y67 so
that a target adenosine was located within every possible
PTC context. All DNA oligonucleotides and gene blocks
were purchased from Integrated DNA Technologies, Inc.
(Coralville, IA, USA). The sequences of all constructs were
verified by Sanger DNA sequencing and are given in Sup-
porting Table S2 and Supporting Sequences S1.
N-DD production in Pichia pastoris
Purification of all versions of N-DD from Pichia pastoris
has been described previously (11,22–24) and the proto-
col remains unchanged. In brief, N-terminal FLAG and C-
terminal HIS-tagged constructs were cloned into the SpeI
site of pPICZA-FLIS6 and transformed into Pichia pas-
toris strain SMD116H. Colonies able to grow on YPDS
agar plates (1 % yeast extract, 2 % peptone, 2 % glucose,
2 % agar and 1 M sorbitol) supplemented with 1500 g/ml
Zeocin® were selected for expression. For protein purifica-
tion, 500 ml cultures were grown in BMGY (1% yeast ex-
tract, 2 % peptone, 100 mM potassium phosphate, pH 6.0,
1.34 % yeast mannitol broth, 4 × 10−5 % biotin, and 1%
glycerol) until OD600 reached 3 and then induced by chang-
ing the media to BMMY (same as BMGY but with 0.5 %
methanol instead of 1 % glycerol). Cells were disrupted us-
ing a French Pressure Cell and proteins were purified by se-
quential Ni2+-nitriloacetic acid column (QIAGEN, Hilden,
Germany) and -FLAG M2 column (Sigma-Aldrich, St
Louis, MO, USA) purifications. Examples of purified pro-
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In vitro editing assays
In vitro editing assays on CFTR RNA were performed
as described previously (11). All in vitro editing assays on
mCherry-eGFP W58X RNA were performed as described
below. Prior to the editing assay, the RNA guide was an-
nealed to the target RNA using a temperature ramp from 65
to 25◦C, decreasing 1◦C every 15 s. For reaction rate experi-
ments, editing assays were performed under single turnover
conditions at either 15◦C or 35◦C and time points were
taken at 0, 1, 2, 5, 10, 20, 40, 60, 120 and 240 min. All assays
contained 20 fmol target RNA, 200 fmol guide RNA (either
1BoxB or 2BoxB Guide), 360 fmol editase, 5 mM DTT, 5
nM PMSF, 0.5 g/ul tRNA and 1 U/ul murine RNase in-
hibitor, all in Q200 [50 mM Tris-glutamate pH 7.0, 200 mM
potassium glutamate, and 20 % (w/v) glycerol]. For extrap-
olating reported reaction rates from other ADARs to 15◦C,
a Q10 of 3.2 was used [Q10 = (R2/R1)10/(T2-T1)]. This value
was based on measurements of N-DD editing of mCherry-
eGFP W58X at 15◦C and 35◦C.
Quantification of editing efficiency in vitro
Quantification of editing efficiency was performed by RT-
PCR and direct sequencing of PCR products as previ-
ously reported (11). Quantification was based on C/T peak
heights of the anti-sense strand because it is more accurate
than estimates based on the A/G peak heights of the sense
strand (21,25). However, it should be noted that for display
in the figures and supporting material all electropherograms
have been reverse complemented for the sake of clarity of
presentation. To estimate in vitro editing rates for all reac-
tions except 2boxB N-DD, reaction kinetics were fit to an
equation of the form E = Emax (1 − e−kt), where E = in-
osines produced, Emax = maximum inosine production, k
= rate constant (min−1) and t = time in minutes. Data for
2boxB N-DD required a double exponential of the form
E = Emax + E1 * e−k1t + E2 * e−k2t, where E1 and E2 are
fractional editing amplitudes and k1 and k2 are distinct rate
constants.
Editing assays in HEK293T cells
HEK293T cells (CRL-11268 ATCC, Manassas, VA) were
maintained in Dulbecco’s Modified Eagle’s Medium supple-
mented with 10 % (v/v) fetal bovine serum, 1% penicillin–
streptomycin solution, 1 mM sodium pyruvate, and 2 mM
glutamine. For each transfection, 0.75 – 3 × 105 cells were
seeded in a 35 mm glass-bottom dish and transfected with
plasmid DNA two days later. The Effectene® Transfection
Reagent kit (QIAGEN, Hilden, Germany) was used accord-
ing to protocol. All components were co-transfected and the
following amounts were used for each transfection: pcDNA
3.1 (−) mCherry-eGFP or mCherry-eGFP W58X (25 ng),
pcDNA 3.1 (+) N-DD, (1–5 N-DDs and E488Q mu-
tants; 100 ng) and U6 pENTR guide RNA vector (2 g).
For negative controls, the siLacZ U6 RNAi vector that was
supplied with the kit was used for transfection in an equal
proportion. For controls in the determination of off-target
edits, we substituted equal amounts of the following plas-
mids for the experimental 1boxB and 2boxB RNA guides:
pcDNA 3.1(−), pUC18, and siLacZ. Cells were analyzed
24, 48, 72 and 96 h post-transfection for the time-course ex-
periments. For all other experiments cells were analyzed 96
h after transfection.
To determine the extent of eGFP fluorescence correction,
cells were imaged with the Cellometer® Vision imaging sys-
tem (Nexcelom Bioscience, Lawrence, MA, USA) using the
dual fluorescence mode. Two monochromatic LED mod-
ules were used as the excitation light sources (470 and 525
nm). Each LED was combined with the specific emission fil-
ters VB535 and VB595. Raw data were taken from the FCS
Express Software (De Novo, Los Angeles, CA, USA) and
analyzed in Excel. We selected cells with red fluorescence
of over 10,000 counts to ensure minimal background con-
tamination. In order to calculate eGFP correction, we first
determined the green to red fluorescence ratio of cells trans-
fected with mCherry-eGFP WT and the precise version and
quantity of the editing enzyme and guide RNA used for that
experiment. Based on this, we estimated the expected green
fluorescence for every mCherry-eGFP W58X cell if correc-
tion were at 100 %. Using this number, we could estimate the
proportion of correction. Average eGFP fluorescence was
measured for 200–800 cells from each experiment, and each
experiment was replicated to ensure consistency. One-way
ANOVA and the Tukey’s test were used for mean compar-
isons using P<0.001.
To determine editing efficiency based on mRNA correc-
tion, total RNA samples were extracted from transfected
HEK 293T cells using the RNaqueous kit according to pro-
tocol as described before (11). cDNA was synthesized using
gene-specific RT-primers and amplified by PCR. The final
product was directly sequenced and quantified as described
above. Off-target edits were also identified by RT-PCR fol-
lowed by direct-sequencing. We used 9 % as a threshold for
calling an off-target edit. This number was based on the av-
erage C/T ratio (antisense sequence) plus one standard de-
viation for 50 random adenosines in assays that lacked an
editing enzyme.
Confocal microscopy
Images were acquired on a specially designed Zeiss Spin-
ning Disk Confocal Imaging System (Zeiss Examiner Z1
Microscope) using a 63X (wet) objective. The same field of
cells was excited with either a 488 nm laser for mCherry or
a FITC light source for eGFP and emission filter Em01-
R488/568 using constant exposure and intensity settings.
Cells were imaged in serum free Opti-MEM® (Life tech-
nologies, Carlsbad, CA, USA) supplemented with 10 % fe-
tal bovine serum, 20 mM HEPES pH 7.4, 1 mM sodium
pyruvate and 2 mM glutamine. Confocal images were used
strictly for presentation in the figures. All data analysis was
performed on large fields of cells using the Cellometer®
Vision as described above.
RESULTS
The goal of this study was to systematically improve a ge-
netically encoded version of our system for SDRE so that
it could efficiently and selectively edit a target A in human
cells. Our system is multipart (Figure 1A); therefore we fo-
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Figure 1. Positions of RNA editing sites relative to boxB in the RNA guide. (Ai) A schematic of the components in our basic system of SDRE. The target
A (shown in red) is located at a position 19 nt on the 3′ side of the boxB hairpin. Our normal guide RNAs contain a C mismatch (shown in blue) with the
target A. (Aii) Experiments were performed in vitro with 20 RNA guides and detailed results of editing at every A is given in Supporting Table S3. Editing
hot-spots are highlighted in red, n = 3.
An antisense guide RNA directs the enzymatic reaction to
a specific adenosine and also provides a nominally double-
stranded structure which is required for deamination (5).
The catalytic domain of ADAR performs the editing reac-
tion. The two are linked through an interaction between the
N peptide, attached to the catalytic domain, and a boxB
RNA hairpin, attached to the RNA guide. In our previ-
ous study (11), a fully genetically encoded version of SDRE
edited at a low efficiency in cells. In addition, because of
variability, it was difficult to accurately quantify editing ef-
ficiency in cells. In the present study, we explored the im-
portance of guide oligo design, the linkage between the N
and the guide, and the catalytic rate of the DD on edit-
ing efficiency. We also examined off-target editing within
the targeted mRNA, in random endogenous targets and at
adenosines known to be edited in humans.
Geometry of guide RNA design
We first focused on the architecture of the guide RNA. At
the outset, our basic guide RNA consisted of a boxB loop
that was 19 nt on the 5′ side of the target adenosine (to avoid
confusion, all references to 5′ and 3′ correspond to the tar-
get mRNA and not the RNA guide; see Figure 1Ai). We hy-
pothesized that geometric constraints could limit the access
of the deaminase domain to the target A. These constraints
could be due to the space occupied by boxB, N and the
catalytic domain, or to constraints imposed by the orienta-
tion of these elements when N is bound to boxB. Accord-
ingly, we decided to test whether the distance between the
target A and the boxB loop makes a difference. In addition,
we wanted to see if editing could occur on both the 5′ and
3′ side of boxB. To test these questions, we modified our
guide design such that the boxB loop was surrounded by
a symmetrical 25 nt complementary to the target on either
side (Figure 1Aii). Using this architecture, 20 guide RNAs
were designed to different regions of a common message,
and their ability to drive editing by N-DD was examined in
vitro (Supporting Figure S2 and Supporting Tables S3 and
S4). Because many guides were tested, we were able to ex-
amine editing of A’s at every position on both the 5′ and 3′
sides of boxB.
In general, editing efficiency varied between positions. A’s
close to boxB (3 nt on the 5′ side and 4 nt on the 3′ side),
were not edited. However, many examples of efficient edit-
ing (>50 %) were observed on both sides of boxB and Fig-
ure 1Aii summarizes the results (for a detailed description of
experiments see supporting material mentioned above). In
general, we found that the well-established neighbor prefer-
ences of human ADAR2 (20,21) were more influential than
the precise position of the boxB loop. Therefore, manipulat-
ing the distance between boxB and the target A appears not
to be a useful strategy for improving our system. The obser-
vation that efficient editing was observed on either side of
the boxB loop was important, however, and this fact led to
an improvement in RNA guide design as described in up-
coming sections. Moving forward, we decided to continue
using our standard guide with the target adenosine 19 nt
on the 3′ side of boxB because this position was edited effi-
ciently. We also elected to introduce a cytosine (C) mismatch
opposite the target adenosine because this has been shown
to increase editing efficiency by others (16,26,27).
A fluorescence reporter system to calibrate the extent of edit-
ing in single cells
Because our immediate goal was to improve editing effi-
ciency in transiently transfected human cells, we needed a
method to quickly and accurately assess correction. An ob-
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Figure 2. Fluorescent reporter system for quantifying editing. (A) Car-
toons of fluorescent protein constructs and plasmids used in this study.
which would fluoresce upon correction. In our previous
study, we used an eGFP reporter; however, because the
efficiency of transient transfections varied, it was difficult
to quantitatively assess correction. What we needed was
an internal calibration for each cell. Accordingly, we de-
signed a dual fluorescent reporter system (28) consisting
of mCherry and eGFP in tandem separated by the self-
cleaving 2A peptide and a FLAG epitope-tag (29; Figure
2A). The 2A peptide was added to avoid potential arti-
facts caused by Fluorescence Resonance Energy Transfer
between eGFP and mCherry. Western Blots of HEK 293T
cells transiently transfected with this construct showed that
2A peptide cleavage was complete (Supporting Figure S3).
When this construct was transfected into HEK 293T cells,
we could measure a consistent ratio between red and green
fluorescence (first panel Figure 2B). Therefore, the red flu-
orescence was an accurate predictor of green fluorescence.
Next we introduced a PTC (W58X) into eGFP. As expected,
cells transfected with this construct showed only red fluo-
rescence (second panel Figure 2B). It should be noted that
the adenosine in the W58X PTC (UAG) was in an opti-
mal context for conversion back into the wild-type tryp-
tophan (UGG) by editing. In order to correct W58X, we
transfected plasmids encoding mCherry-eGFP W58X and
N-DD, driven by CMV promoters, and a plasmid encod-
ing a guide RNA, driven by a U6 promoter (Figure 2A).
The fifth panel in Figure 2B shows restoration of green flu-
orescence. When either N-DD or the guide RNA contain-
ing plasmids were omitted, no green fluorescence was evi-
dent (panels 3 and 4 in Figure 2B). Based on red fluores-
cence, we estimated that we restored 11% of eGFP fluo-
rescence. Direct sequencing of mCherry-eGFP W58X RT-
PCR products from the same reactions gave the same value
(11 %; Figure 2C). It should be noted that in all cases de-
scribed throughout this paper, estimates of correction based
on direct sequencing and fluorescence measurements were
in close agreement (Supporting Figure S4). Fluorescence
measurements and RNA samples were taken 96 h post-
transfection. Earlier time points also showed correction, al-
beit to a lesser extent (Figure 2D). These data confirmed
that the dual reporter system could be used to accurately
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Full-length mCherry and eGFP were fused together and separated by a
2A peptide (black) followed by a FLAG epitope tag (grey). In addition,
a version with a stop codon (UAG) inserted at position 58 of eGFP was
made (W58X). These constructs were cloned into a vector driven by the
CMV promoter, as was N-DD. RNA guides were driven by a U6 pro-
moter. (B) Confocal images of HEK293T cells transfected with different
combinations of components are shown. Red, green, and DIC images are
shown for the same field of cells. Pictures are taken 96 h post-transfection.
Scale bars = 12 m. Fluorescence correction was estimated to be 11 ± 0.05
%. (C) Sequences from RT-PCR products of corrected cells and cells trans-
fected with mCherry-eGFP W58X alone. Asterisks indicate the target A.
Editing percentage for experimental samples was estimated to be 11 %. (D)
Estimates of editing efficiencies from fluorescence (dark gray) and direct
sequencing (light grey) were compared at various days post-transfection.
Fluorescence estimates were based on 200–800 cells per sample (mean ±
SEM) and RT-PCR products came from the same samples. Technical du-
plicates for all fluorescence measurements yielded similar results (2.3 ± 0.3,
8.7 ± 1.5, 8.9 ± 1.5, and 12.9 ± 1.4 % for days 1, 2, 3, and 4, respectively).
Technical duplicates for RNA correction based on direct sequencing of
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assess functional correction by SDRE. They also confirmed
that the editing efficiency of our system was low.
Multiple N peptides improve RNA editing efficiency
To improve SDRE, we focused on the linkage between the
deaminase domain and the guide RNA. Our system is two
part, and for editing to occur the deaminase domain must
bind to the guide via the N:boxB interaction (11). We rea-
soned that the affinity of this interaction could be an im-
portant determinant of editing efficiency, and that the ap-
parent affinity could be increased by adding more Ns or
boxBs. We first looked at the effects of adding more Ns.
To test whether this strategy was sound, we added an extra
N to the amino terminus of N-DD (Figure 3Ai) and puri-
fied both the 1N-DD and 2N-DD versions from the yeast
Pichia pastoris (11,22–24). These enzymes were then com-
bined with our standard guide and mCherry-eGFP W58X
RNA in vitro and reaction kinetics were monitored under
single-turnover conditions (Figure 3Aii). The addition of
the extra N increased the reaction rate from 0.1 ± 0.02 to
0.3 ± 0.05 min−1. In addition, it increased the maximum
editing percentage from 63.4 ± 2.7 to 90.9 ± 1.1 %. We
next tested the effects of extra Ns in cells. Constructs with
1–5 Ns were transfected into HEK293T cells and editing
was assessed using our standard assay. Editing efficiency
based on fluorescence correction increased from 11 to 35
% with 4N-DD (Figure 3Aiii). There was no statistically
significant improvement between 4N-DD and 5N-DD.
Direct sequencing, which measured editing at 39 %, was in
good agreement with the fluorescent measurements. Thus,
increasing the number of protein binding partners increased
editing efficiency.
Two boxB hairpins improve RNA editing efficiency further
We next asked whether increasing the number of boxB bind-
ing partners would also increase efficiency. Data from Fig-
ure 1 demonstrated that N-DD could edit efficiently on
both the 5′ and 3′ sides of boxB. It also showed that a target
adenosine 11 nt on the 5′ side was as efficiently edited as one
19 nt on the 3′ side. Based on this, we designed a guide with
2 boxBs, making the target adenosine 11 nt on the 5′ side of
one and 19 nt on the 3′ side of the other (Figure 3Bi). We
first tested the 2 boxB guides in vitro using purified N-DD
under single turnover conditions. The 2 boxB guide visibly
increased the reaction rate (Figure 3Bii); however, the reac-
tion kinetics were complex and could not be well fit with
a single exponential rate constant. The maximum editing
percentage increased from 63 ± 2.7 to 95 ± 0.4 %. We then
tested the two boxB guide with enzymes containing 1–4 Ns
in HEK293T cells using our reporter assay (Figure 3Biii).
The combination of two boxB and four Ns increased the
editing percentage to 64 %, as measured by fluorescence,
and 57 %, as measured by direct sequencing. Regardless of
the number of Ns on the editing enzyme, the additional
boxB increased editing (compare Figure 3Aiii and Biii) and
the difference was significant in all cases. Thus, increasing
the number of RNA or protein binding partners increased
editing efficiency. To further improve our strategy, we then
looked to modify other elements in our system.
The E488Q mutation in the deaminase domain improves
RNA editing efficiency
We next decided to directly manipulate catalysis within the
deaminase domain. A previous study showed that a sin-
gle mutation in a conserved loop near the catalytic center
of WT hADAR2 (E488Q), increases the enzyme’s catalytic
rate (30), and it also increases the affinity, and activity, of
the isolated deaminase domain for a substrate RNA (31).
We added the E488Q mutation to both N-DD and 4N-
DD in HEK293T cells (Figure 4A). In both cases, the muta-
tion led to a large increase in editing efficiency. A casual ob-
servation of the transfected cells showed that green fluores-
cence in 4N-DD E488Q with the 2boxB (Figure 4B) guide
was not noticeably different than WT mCherry-eGFP (Fig-
ure 2B, panel 1). In these assays, editing efficiency was esti-
mated at 69% by fluorescence and 72 % by RT-PCR (Figure
4C). Thus, the combination of the catalytic mutant with the
manipulations of N and boxB resulted in an increase in
editing from ∼11 % to ∼70 %. Nevertheless, as noted be-
fore, our reporter system uses an A in an optimal context
(UAG) and therefore we would predict that these editing
percentages are a best case scenario.
Optimized system for SDRE edits different PTCs
We next explored the ability of our improved SDRE system
to edit A’s in different neighboring contexts. For these exper-
iments, we focused on A’s within PTCs in all possible con-
texts. To quantify editing, we relied exclusively on RT-PCR
(there were not the appropriate tryptophan codons within
eGFP to create the constructs to test all permutations via
fluorescence). For the UAG and UGAN contexts (codon
underlined), correction requires a single deamination. How-
ever, for the four UAAN PTCs, two deaminations are re-
quired and thus we estimated correction as the product of
the fractional conversion for both; however, we also present
data for the conversion efficiency of each individual adeno-
sine (Figure 5B). As expected from the nearest neighbor
preferences of the deaminase domain (21), the UAG PTC
was edited best (Figure 5A). For UGAN PTCs, the identity
of the 3′ neighbor is important. UGAG is edited most ef-
ficiently by both 4N-DD and 4N-DD E488Q. 4N-DD
edits all other 3′ neighbors poorly. 4N-DD E488Q can
edit UGAU and UGAA at high levels but UGAC more
poorly. Based on the established nearest neighbor rules, we
would have expected UGAC to be edited more efficiently.
For UAAN PTCs, the 3′ neighbor of the second adenosine
is an important factor for 4N-DD E488Q where C = A>G
= U. For 4N-DD, all UAAN PTCs are edited poorly. For
most contexts, 4N-DD E488Q edits better than 4N-DD,
but not always. Thus, when targeting new A’s it would be
prudent to test both.
Off-target RNA editing
Data thus far indicates that A’s in a variety of contexts
can be targeted efficiently. However, we have not examined
whether unintended A’s are edited as well. In our previous
work, we reported moderate off-target editing in eGFP mes-
sages at two positions in transfected HEK293T cells (11).
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Figure 3. Increasing the number of Ns and boxBs improves editing. (Ai) A schematic showing the addition of N-terminal N’s. (Aii) Reaction kinetics
of N-DD and 2N-DD, purified from Pichia pastoris, were measured using mCherry-eGFP W58X in vitro using our standard 1boxB RNA guide. Rate
constants, estimated from fits (see Materials and Methods section), were kobs = 0.1 ± 0.02 and 0.3 ± 0.05 min−1 for N-DD and 2N-DD, respectively.
Experiments were performed at 35◦C. Constructs with 1–5Ns connected to DD were generated and tested in HEK293T cells using the fluorescent reporter
assay (dark gray) and by RT-PCR (light gray; Aiii). Technical duplicates for all fluorescence measurements yielded similar results (11.6 ± 0.5, 19.2 ± 0.9,
32.1 ± 1.3, 38.5 ± 0.7 and 35.7 ± 1.3 % for 1–5N-DD, respectively). Technical duplicates for RNA correction were as follows: 8, 27, 32, 48 and 41 % for
direct sequencing measurements of 1–5N-DD, respectively. (Bi) 1boxB and 2boxB RNA guides. With the 2boxB guide, the target A (red) is 19 nt 3′ to
boxB 1 and 11 nt 5′ to boxB 2. (Bii) The kinetics of editing using a 1boxB or 2BoxB guide was tested with purified N-DD and mCherry-eGFP W58X
in vitro. Temperature = 35◦C. The data for 2boxB was fitted to a double exponential and the rate constants were k1obs = 1.54 ± 0.09 and k2obs = 0.05 ±
0.001. (Biii) Editing efficiency of 2boxB guide was tested in HEK293T cells using 1–4N-DD. As before, correction was estimated by both fluorescence
(dark gray) and direct sequencing (light gray). All results were tested with a one-way ANOVA and Tukey’s test. An asterisk indicates significance (P <
0.001) and NS = not significant. Technical duplicates for all fluorescence measurements yielded similar results (16.9 ± 0.5, 32.9 ± 1.1, 39.4 ± 1.0 and 54.5
± 1.9 % for 1–4N-DD, respectively). Technical duplicates for RNA correction were as follows: 13, 30, 48 and 57% for direct sequencing measurements of
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Figure 4. E488Q mutation introduced into DD increases editing efficiency.
(A) Schematic of the E488Q mutation in N-DD or 4N-DD. (B) Con-
focal images of HEK293T cells transfected with various components of
SDRE. Scale bars = 12 m. (C) Quantification of correction in transfec-
tions by both fluorescence (dark gray) and direct sequencing (light gray).
All values for fluorescence correction are significantly different by ANOVA
and Tukey’s test. n = 200–800 cells, mean ± SEM. Technical duplicates
for all fluorescence measurements yielded similar results (11.5 ± 0.1, 32 ±
0.2, 58.9 ± 2.1 and 65 ± 0.02 for N-DD 1boxB, N-DD E488Q 1boxB,
4N-DD 2boxB and 4N-DD E488Q 2boxB, respectively). Technical du-
plicates for RNA correction were as follows: 7, 27, 69 and 70 % for direct
sequencing measurements of N-DD 1boxB, N-DD E488Q 1boxB, 4N-
DD 2boxB and 4N-DD E488Q 2boxB, respectively.
5' A A 3' 
Rep1 Rep2 Rep1 Rep2
4λN-DD
U 52.8 53.0 47.8 43.7 G
U 39.8 47.8 17.5 22.3 C
U 37.1 39.5 23.1 28.0 A
U 29.8 26.9 16.6 14.1 U
4λN-DD 
E488Q
U 47.6 52.0 49.3 55.2 G
U 74.4 78.0 73.1 68.0 C
U 63.3 74.0 65.6 70.0 A
U 49.0 50.0 52.0 49.7 U
4λN-DD rep 1
4λN-DD rep 2
4λN-DD E488Q rep 1
4λN-DD E488Q rep 2
A
B
Figure 5. Editing efficiencies of optimized SDRE system on A’s in differ-
ent neighboring contexts. (A) A’s in different neighboring contexts were in-
troduced into mCherry-eGFP and different 2boxB guide RNAs were de-
signed to target them. These RNA guides were tested in HEK293T cells
with either 4N -DD or 4N-DD E488Q. Results were tested only by di-
rect sequencing of RT-PCR products. Experiments were done in duplicate.
(B) Editing percentages of individual A’s for the UAAN context with 4N
-DD and 4N-DD E488Q. Rep 1 = repetition 1 and rep2 = repetition 2.
efficiency, we decided to revisit the question of off-target
editing. Using 4N-DD, there were 11 off-target edits in
mCherry-eGFP transcripts (Supporting Table S1 and Fig-
ure 6). Of these, three were in a region complementary to
the guide RNA and the rest outside of it. For 4N-DD
E488Q, there were 13 (all 11 of the WT plus 2 additional
ones; see Supporting Figure S5). In general, the efficiency of
off-target editing is higher with the E488Q mutation. Next,
we explored factors that might contribute to off-target edit-
ing (Supporting Table S1). For both E488Q and the WT
deaminase domain, the number of N peptides had little
influence on off-target edits outside of the region comple-
mentary to the RNA guide. Off-target edits complemen-
tary to the RNA guide were generally more severe with 4N
peptides than with 1. The number of boxBs in the RNA
guide had little effect on off-target editing. Taken together,
this data implies that the N-boxB interaction is not re-
quired for off-targets outside of the region complementary
to the RNA guide, but it is important for those underneath
the guide as well as for the on-target editing site. To test
this idea, we mutated N within N-DD, 4N-DD, N-























































Figure 6. Off-target edits in mCherry-eGFP RNAs. Relationship between
the amount of 2boxB RNA guide plasmid transfected and off-target edits.
Codon numbering on the abscissa is for mCherry-eGFP. W58X is the on-
target edit. P57P, P59P and T60A are in a region complementary to the
RNA guide. Results for 4N-DD are presented in panel (A) and for 4N-
DD E488Q in panel (B). All percentages are based on direct sequencing of
RT-PCR products. n = 4, mean ± SEM.
disrupt the interaction with boxB (R7K, R8K and R11K;
32–34). We also made constructs that lacked the Ns alto-
gether (DD and DD E488Q). In general, these constructs
yielded less off-target editing but the effect was not dra-
matic as most sites persisted. On-target editing however,
was drastically reduced in all cases, demonstrating the re-
quirement for the N-boxB interaction. These results indi-
cate that the overexpression of the deaminase domain alone
leads to some off-target editing; however, the relationship
appears complex.
We next explored the relationship between the RNA
guide and off-target editing (Supporting Table S1). First,
we tested whether directing a guide to mCherry-eGFP was
required for off-target editing. Here, we used a non-specific
2boxB guide directed against another target (U6 CFTR
2boxB) with 4N-DD and 4N-DD E488Q. Surprisingly,
off-target edits were almost identical to those produced with
a specific guide. We next tested whether driving a random
siRNA (U6 siLacZ) instead of a 2boxB guide would pro-
duce the same effect, and it did. However, when we replaced
our U6 vector driven guides with generic plasmids (pcDNA
3.1(−) and pUC18), off-target edits were largely abolished
with 4N-DD. For 4N-DD E488Q, off-target edits were
also largely abolished for pcDNA 3.1(−) but only dimin-
ished for pUC18. These data indicate that there is a corre-
lation between RNA overexpression and off-target editing
and these events are more persistent when using the E488Q
mutation. Accordingly, we decided to explore whether we
could reduce off-target editing by decreasing the amount
of RNA guide transfected (Figure 6). With 4N-DD, by
reducing the amount of guide RNA from 2 to 1.5 g per
transfection, all but one off-target (K97R) was abolished
while on-target editing was still robust (∼40 %; reduced
from ∼60 %). By using 0.5 g of RNA guide, all off-targets
were abolished, leaving ∼25 % on-target editing. With 4N-
DD E488Q, off-targets are more persistent. Off-target ed-
its were not as sensitive to dilutions of the editing enzyme
where both on-target and off-target events decrease more or
less concomitantly (Supporting Figure S6). Thus at present,
a careful titration of the guide RNA appears to be impor-
tant for controlling off-target edits.
We also explored whether our system produced off-target
edits in mRNAs that were not targeted by our guide. For
these experiments we transfected 4N-DD and 4N-DD
E488Q with 2 g of 2boxB, conditions that produced ro-
bust off-targets in mCherry-eGFP. For these experiments,
we amplified and directly sequenced 800–1200 nt portions
from five messages expressed in HEK293T cells (hTRPC3,
hATP1A1, hATP1B1, hATP1B2 and hEDG3). We did not
observe any off-target edits in these sequences. We also
looked at four adenosines in three mRNA substrates that
are known to be edited in humans (Supporting Table S5;
35–38). For GLI1 nt 2101, we observed no editing in non-
transfected HEK293T cells. For cells expressing either edit-
ing enzyme, we observed approximately 30% editing that
could be reduced to 15% by using 0.5 g of 2boxB guide
RNA. For NEIL1 nt 725, we observed ∼80% editing in
WT cells. 4N-DD had little effect on this site but 4N-DD
E488Q increased editing by ∼10%. For NEIL1 nt 726, we
observed ∼35% editing which was about doubled with each
editing enzyme at high guide concentrations but unaffected
at low concentrations. For AZIN1 nt 1099, we did not de-
tect editing under any condition.
Comparison of catalytic rate of SDRE versus WT ADARs
Relying on a guide RNA instead of dsRBMs, our system for
SDRE is fundamentally different than RNA editing by WT
ADAR. Although the catalytic rate of WT ADAR varies
according to the specific RNA substrate, we wanted to get
a general idea of how our system compared. We purified
4N-DD WT and 4N-DD E488Q from yeast and mea-
sured the catalytic rates on the mCherry-eGFP W58X RNA
in vitro under single-turnover conditions (Figure 7A). The
reactions were too fast to accurately measure at our stan-
dard temperature of 35◦C, so we reduced the temperature
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Figure 7. Kinetics of improved system for SDRE compared to reported
values for hADARs. (A) In vitro kinetics of purified 4N-DD and 4N-
DD E488Q were measured using a 2boxB guide RNA and mCherry-
eGFP W58X. Temperature = 15◦C. n = 3, mean ± SEM. (B) Table of
reported values for kobs extrapolated to 15◦C using a Q10 of 3.2 (see Mate-
rials and Methods section). Published values for WT hADAR1, hADAR2,
hADAR2 E488Q and hADAR2 DD were measured at either 20◦C or
30◦C.
for 4N-DD WT was 0.03 ± 0.004 min−1 and for 4N-
DD E488Q was 0.06 ± 0.003 min−1. Published values for
WT hADAR1, hADAR2, hADAR2 E488Q and hADAR2
DD were all measured at higher temperatures (20◦C and
30◦C; 30, 31, 39–43). Accordingly, we estimated the corre-
sponding values at 15◦C using a Q10 of 3.2 (see Methods
Section). The rate constants for both 4N-DD and 4N-
DD E488Q are about an order of magnitude higher than
those for hADAR1 on the NEIL1 K/R site (39) and the
hADAR2 GluR-B Q/R site (30; Figure 7B). They are sim-
ilar to the rate constant given in one report of hADAR2
on the GluR-B R/G site (41). For all other hADAR2 sub-
strates (30,31,40) they are about an order of magnitude
slower. For reports on the hADAR2 deaminase domain on
the highly editable Bdf2 R/G site (31), and for hADAR2
E488Q on the GluR-B R/G site (30), they are ∼2 orders of
magnitude slower. We therefore conclude that our system
edits with similar kinetics as WT ADARs on poorer sub-
strates.
DISCUSSION
In this work, we have improved the N-DD system for
SDRE in cells from one that edits a small fraction of the tar-
gets A’s to one that edits them in the majority of messages,
provided that they are in an optimal context. Other con-
texts are also edited efficiently, but not all. Increases to the
apparent affinity between the DD and the guide RNA, and
increases to the catalytic efficiency of the DD were the ma-
jor factors underlying the improvement. Our progress de-
pended on a dual colored fluorescence reporter system that
enabled us to calibrate editing within individual cells. Even
though improvements have been made, there are still signif-
icant limitations that must be overcome to realize the full
potential of SDRE.
Although the target A can be converted efficiently, off-
target edits occur. In general, there were two classes of
off-target edits: those that occurr in sequence complemen-
tary to the RNA guide and those that occurr outside of
it. The first can presumably be controlled by manipulat-
ing the guide sequence (e.g. introducing an A:G mismatch;
11,16,26). The second are more problematic. They could
be caused by endogenous, editable structures within the
mRNA that are accessible to the docked editing enzyme. In
fact, a new method for identifying the targets of RNA bind-
ing proteins takes advantage of this activity (44). By attach-
ing the deaminase domain of hADAR2 to RNA binding
proteins, their binding partners can be identified by looking
for A or G discrepancies in transcriptome sequencing. This
highlights the probability that any method that tethers an
ADAR deaminase domain to an RNA can lead to off-target
events, whether or not an exogenous double-stranded struc-
ture is provided with an RNA oligonucleotide. It is also con-
ceivable that off-target edits could be due to the RNA guide
binding to unintended places within the mRNA, but we see
no evidence of guide complementarity outside of the target.
Our data also reveals a complex relationship between RNA
overexpression and off-target edits. By carefully titrating
the amount of guide RNA used, off-target events can be
controlled but at the expense of some on-target editing ef-
ficiency. For the mCherry-eGFP message, the use of the
E488Q mutation does not appear to be warranted because
the modest increase in on-target editing is outweighed by
a large increase in off-target editing. Thus, the benefits of
this mutation should be determined empirically for each tar-
geted message. We have not yet assessed transcription-wide
off-target edits and this is undoubtedly an important step;
however, sequencing of a set of random mRNAs revealed
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of naturally occurring substrates, on the other hand, were
modestly affected by SDRE. In general, these data hint at
a strategy for reducing off-targets in the future: by increas-
ing the affinity of the editing enzyme for the on-target sites
relative to the off-target sites, all components, including the
guide RNA, could be delivered in lower amounts.
In addition, manipulations to the guide RNA could con-
ceivably increase the affinity of N-DD for the target A.
At present, the guide RNA has a C mismatch under the
target, but the rest is perfectly complementary to its bind-
ing partner. Naturally occurring RNA editing substrates do
not look like this, having more mismatched positions (6,45–
48). The key will be to decide where to put mismatches in
the guide RNAs. Molecular modelling or high-throughput
screens may help solve this problem. The introduction of
mismatches to guide RNAs may also improve editing of A’s
in poor neighboring contexts. Another strategy for improv-
ing SDRE is to use DDs from different ADARs (16), or to
select for further mutants within the DD of hADAR2. In
our system, we have elected to use the deaminase domain
from hADAR2 because this enzyme is known to underlie
most recoding events in humans. However, it is likely that
adenosines which lie in specific contexts might be best con-
verted using a different catalytic domain or at least by in-
troducing targeted mutations. The recent structure of the
catalytic domain of hADAR2 bound to an RNA substrate
will be a tremendous benefit in these efforts (49). Finally,
editing using our system presumably takes place in the cyto-
plasm because the nuclear localization signal of hADAR2
resides at the amino-terminus, a region we have removed
(50). This stands in contrast with endogenous RNA edit-
ing which takes place in the nucleus at the level of pre-
mRNA (6,46,51). Perhaps driving editing within the nucleus
could reduce off-target events. A better optimized system
for SDRE would be useful for biological research or thera-
peutic applications.
A major difference between SDRE and genome editing
is that the first is transient and the second permanent. It
should be noted that most therapeutics are transient as well,
so targeting genetic information within RNA has advan-
tages in some cases. Even for hereditary diseases, where a
permanent correction would be desirable, SDRE has advan-
tages: off-target changes are not as dangerous in a transient
system and RNA is more accessible than DNA. A signif-
icant disadvantage with SDRE at present is the fact that
it is limited to A to I changes; however, other RNA mod-
ification systems exist, the most notable being the cytosine
deaminases which convert cytosine to uracil (52). For future
applications SDRE holds much promise. Not only can it be
used to correct genetic defects but also to fine-tune protein
function.
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